STAMATAKOS, SERENA

STAMATAKOS, SERENA  

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

Dottorandi  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.019 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy Lucia Carboni; Laura Rullo; Francesca Felicia Caputi; Serena Stamatakos; Sanzio Candeletti; Patri...zia Romualdi 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-23-14041 (1).pdf
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences Costa G.; Caputi F.F.; Serra M.; Simola N.; Rullo L.; Stamatakos S.; Sanna F.; Germain M.; Martin...oli M.-G.; Candeletti S.; Morelli M.; Romualdi P. 2021-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-12-713486.pdf
Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice Bastianini S.; Lo Martire V.; Alvente S.; Berteotti C.; Matteoli G.; Rullo L.; Stamatakos S.; Sil...vani A.; Candeletti S.; Romualdi P.; Cohen G.; Zoccoli G. 2021-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista BastianiniSREP2021.pdf41598_2021_3468_MOESM7_ESM.zip
Nociceptive behavior and central neuropeptidergic dysregulations in male and female mice of a Fabry disease animal model Rullo L.; Posa L.; Caputi F.F.; Stamatakos S.; Formaggio F.; Caprini M.; Liguori R.; Candeletti S....; Romualdi P. 2021-01-01 BRAIN RESEARCH BULLETIN - 1.01 Articolo in rivista -
Targeting the JAK/STAT Pathway: A Combined Ligand- And Target-Based Approach Galvez-Llompart M.; Ocello R.; Rullo L.; Stamatakos S.; Alessandrini I.; Zanni R.; Tunon I.; Cava...lli A.; Candeletti S.; Masetti M.; Romualdi P.; Recanatini M. 2021-01-01 JOURNAL OF CHEMICAL INFORMATION AND MODELING - 1.01 Articolo in rivista acs.jcim.2021_1.pdf
The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms Caputi F.F.; Di Cesare Mannelli L.; Rullo L.; Micheli L.; Stamatakos S.; Posa L.; Ghelardini C.; ...Romualdi P.; Candeletti S. 2020-01-01 BIOCHEMICAL PHARMACOLOGY - 1.01 Articolo in rivista TrackChangesCaputietal.2020Bioch Pharmrev28920(1).pdf
Interplay between the endogenous opioid system and proteasome complex: Beyond signaling Caputi F.F.; Rullo L.; Stamatakos S.; Candeletti S.; Romualdi P. 2019-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-20-01441.pdf
Modulation of the negative affective dimension of pain: Focus on selected neuropeptidergic system contributions Caputi F.F.; Rullo L.; Stamatakos S.; Candeletti S.; Romualdi P. 2019-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-20-04010.pdf